Advertisement Pharmaceutical Business review - Page 104 of 5275 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
May 27, 2026

SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative

SK bioscience has signed a vaccine technology transfer and manufacturing agreement with Colombia’s state-owned pharmaceutical company VECOL, becoming part of the country’s $260m vaccine localisation initiative.

The initial product involved is SKYVaricella, SK bioscience’s varicella vaccine, with plans for broader portfolio expansion in future. Credit: SK bioscience.